NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 06/18/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization7,498.74 mln
Float154 mln
Earnings Date07/29/2026
EPS
0.90
Stretched
P / E
49.99
High premium
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-1.4
Manipulation likely
1-Year Forecast
46.12
Fairly priced
Relative Strength
83
/ 100
Strongly outperforming
Business Description
Alkermes is an Irish biopharmaceutical company founded in 1987 that develops and sells medicines for serious mental health and neurological conditions, including schizophrenia, bipolar disorder, and opioid and alcohol dependence. Its approved treatments are sold primarily in the United States, with additional operations in Ireland and other markets. The company also licenses its drug delivery technology to other pharmaceutical firms, supporting their efforts to develop and manufacture their own products.
